Document is current
Any future updates will be listed below
-
Authors
Protudjer, Jennifer L. P.
Mack, Douglas P.
Connors, Lori
Lidington, Jasmin
Kim, Harold
-
Funding
Funding for this research was provided by:
Canadian Society of Allergy and Clinical Immunology
Nutricia
- License Information
-
More Information
Article History
Received: 17 January 2025
Accepted: 4 February 2026
First Online: 10 April 2026
Declarations
:
: As an educational course, the University of Manitoba Research Ethics Board deemed research ethics board approval unnecessary subsequent to review of the course proposal and overview (HS25785 (H2022:389)).
: As an educational course, the University of Manitoba Research Ethics Board deemed research ethics board approval unnecessary subsequent to review of the course proposal and overview (HS25785 (H2022:389)).
: JLP Protudjer is Section Head, Allied Health; and Co-Lead, Research Pillar for the Canadian Society of Allergy and Clinical Immunology, and is on the steering committee for Canada’s National Food Allergy Action Plan. She reports consulting for Ajinomoto Cambrooke, Novartis, Nutricia and ALK Abelló.D Mack has provided consultation and speaker services for DBV, ALK, and Alladapt, Nutricia and is an investigator for DBV and ALK-Abello.L Connors none to declare.J Lidington is a paid employee of the Canadian Society of Allergy and Clinical Immunology.H Kim has participated on Speakers’ bureau and/or advisory boards for ALK, AstraZeneca, Bausch Health, CSL Behring, GSK, Miravo, Novartis, Pediapharm, Pfizer, Sanofi, Shire, Takeda, Valeo.
